Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Invivyd, Inc.
  6. Financials
    IVVD   US00534A1025

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  01:00 2022-11-25 pm EST
2.140 USD   -5.31%
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Development Projects
MT
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2021 2022 2023 2024
Capitalization1 808233--
Enterprise Value (EV)1 216-14858,3156
P/E ratio -1,36x-0,99x-1,22x-1,59x
Yield ----
Capitalization / Revenue ---1,71x
EV / Revenue ---1,14x
EV / EBITDA -0,95x0,69x-0,28x-1,69x
Price to Book 1,45x0,70x1,86x7,38x
Nbr of stocks (in thousands) 111 252108 982--
Reference price (USD) 7,262,142,142,14
Announcement Date 03/30/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2021 2022 2023 2024
Net sales1 ---136
EBITDA1 -227-215-210-91,9
Operating profit (EBIT)1 -227-233-211-144
Operating Margin ----106%
Pre-Tax Profit (EBT)1 -227-236-208-167
Net income1 -227-236-208-156
Net margin ----114%
EPS2 -5,32-2,17-1,75-1,35
Dividend per Share ----
Announcement Date 03/30/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -101-51,7-47,3-41,0-46,5-49,0
Operating Margin ------
Pre-Tax Profit (EBT)1 -101-51,0-45,1-40,3-46,5-49,0
Net income1 -101-51,0-45,1-40,3-46,5-49,0
Net margin ------
EPS2 -0,93-0,47-0,42-0,37-0,42-0,45
Dividend per Share ------
Announcement Date 05/13/202208/15/202211/10/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2021 2022 2023 2024
Net Debt1 ----
Net Cash position1 59138117577,6
Leverage (Debt / EBITDA) 2,61x1,77x0,83x0,84x
Free Cash Flow ----
ROE (Net Profit / Equities) -81,8%-46,6%-87,6%-111%
Shareholders' equity1 277507238140
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share2 5,023,051,150,29
Cash Flow per Share ----
Capex ----
Capex / Sales ----
Announcement Date 03/30/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 233 222 338
Number of employees 102
Free-Float 72,5%
Free-Float capitalization (USD) 169 012 406
Avg. Exchange 20 sessions (USD) 747 815
Average Daily Capital Traded 0,32%
EPS & Dividend